Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) today announced the pricing of the Company’s initial public offering of 5,700,000 shares of common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE